This inventor holds 1 USPTO granted patent. Top assignee: Kainos Medicine Inc.. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Juhan Bok: Innovator in Pharmaceutical Compounds
Introduction
Juhan Bok is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific enzymes. His work is crucial for advancing treatments for various diseases.
Latest Patents
Juhan Bok holds a patent for "Compounds as inhibitors of diacylglycerol O-acyltransferase type 1 enzyme." This invention provides a novel compound that exhibits activity against diacylglycerol O-acyltransferase type 1 (DGAT1). The patent outlines a pharmaceutical composition aimed at preventing or treating diseases modulated by the inhibition of DGAT1. It also describes a method for administering this compound to individuals in need, as well as its use in manufacturing medicaments for similar purposes.
Career Highlights
Juhan Bok is associated with Kainos Medicine Inc., where he continues to innovate in the pharmaceutical sector. His work has the potential to impact the treatment landscape for various conditions linked to DGAT1.
Collaborations
Some of his notable coworkers include Dooseop Kim and Sunmi Shin, who contribute to the collaborative efforts at Kainos Medicine Inc. Their combined expertise enhances the research and development initiatives within the company.
Conclusion
Juhan Bok's contributions to pharmaceutical innovations, particularly through his patent on DGAT1 inhibitors, highlight his role as a key inventor in the field. His work at Kainos Medicine Inc. and collaborations with fellow researchers further underscore the importance of teamwork in advancing medical science.